Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 174   

Articles published

PFE 34.56 -0.21 (-0.60%)
price chart
Will Pfizer Inc. Break Up in 2015?
Pfizer has been churning out major new products such as its pneumonia and meningitis vaccine, Prevnar-13, during this time period.
Pfizer to pay $17 billion for Hospira Inc.  Allentown Morning Call
Pfizer Inc. Is Not Done With Acquisition Deals Yet  Bidness ETC
Has Pfizer Inc. Finally Solved Its Immuno-oncology Problem?
Despite its humble beginnings and numerous setbacks, immunotherapy is on the cusp of becoming a standard part of cancer care, right alongside chemotherapy and surgery.
Interesting June Stock Options for Pfizer
So unless Pfizer Inc sees its shares decline 7.7% and the contract is exercised (resulting in a cost basis of $31.58 per share before broker commissions, subtracting the 42 cents from $32), the only upside to the put seller is from collecting that ...
NICE Okays Pfizer Inc. Inlyta, Rejects Dendreon Corporation Provenge; Bad ...
The National Institute for Health and Care Excellence (NICE) issued two final guidelines today, recommending Pfizer Inc.'s (NYSE:PFE) Inlyta (axitinib) to be used as a second-line treatment option for kidney cancer, while rejecting Dendreon Corporation ...
Pfizer to Buy Hospira for $16 Billion
Pfizer Inc. said Thursday it would buy smaller rival Hospira Inc. in a $16 billion deal that would transform the New York pharmaceutical company into a leading player in the emerging market for lower-priced knockoffs of costly biotech drugs.
Here's why Pfizer's deal for Hospira has a lot going for it  The Globe and Mail
Which Biotech Stock Should Pfizer, Inc. Buy?
Earlier this week, Pfizer announced that it would acquire Hospira, the top provider of injectable drugs. The deal will net Pfizer an intriguing biosimilar program, but some suspect that the company is still hungry for more. If Pfizer is indeed still on ...
Pfizer, Inc., Novartis AG Criticize CDC's Recommendation For Meningitis B ...
Pfizer Inc. (NYSE:PFE) and Novartis AG (ADR) (NYSE:NVS) on Thursday received a green signal from the US Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) for their meningitis B vaccines, for people ...
Pfizer, Novartis say meningitis vaccine scope too narrow  Reuters
5 Things Pfizer, Inc.'s Management Wants You to Know
Times are challenging for Pfizer (NYSE: PFE ) , the largest pharmaceutical company in the world by revenue. In its latest quarterly report, Pfizer delivered a 3% decline in revenue to $13.12 billion as foreign currency translation headwinds and patent ...
Pfizer (PFE) Leading In Pre-Market Activity
Pfizer to cut jobs at Cambridge research center
Drug giant Pfizer Inc. said Tuesday that it plans to pare an unspecified number of jobs at its Cambridge research center, opened last June, as part a broader cutback across its research operations.
Pfizer Inc. (PFE) Closes 0.6% Down on the Day for March 03
Pfizer Inc. currently has a total float of 6.13 billion shares and moves 31.78 million a day, on average. The stock opened at $34.75 on March 03 and traded between a low of $34.41 and a high of $34.89.